ResearcherRoswell Park Comprehensive Cancer CenterActive in the last 2 years
Abdulrahman A. Alahmari
Matched on ORCID iD 0000-0002-7211-3739; OpenAlex author ID A5037920820. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. Co-author DOI 10.1261/rna.079931.123↗
- Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-23-0547↗
- Drivers of Gene Expression Dysregulation in Pancreatic Cancer. First author DOI 10.1016/j.trecan.2021.01.008↗
- Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1101/gr.257550.119↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Swati Venkat · 4 shared papers, 2020–2024 · strength 0.67
- Paper Drivers of Gene Expression Dysregulation in Pancreatic Cancer. DOI 10.1016/j.trecan.2021.01.008↗
- Paper CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. DOI 10.1261/rna.079931.123↗
- Paper Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-23-0547↗
- Michael E. Feigin · 4 shared papers, 2020–2024 · strength 0.67
- Paper Drivers of Gene Expression Dysregulation in Pancreatic Cancer. DOI 10.1016/j.trecan.2021.01.008↗
- Paper CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. DOI 10.1261/rna.079931.123↗
- Paper Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-23-0547↗
- Abigail C. Cornwell · 2 shared papers, 2023–2024 · strength 0.33
- Kathryn E. Maraszek · 2 shared papers, 2023–2024 · strength 0.33
- Katerina V. Gurova · 1 shared paper, 2024 · strength 0.18
- Nina G. Steele · 1 shared paper, 2023 · strength 0.15
- Janusz Franco‐Barraza · 1 shared paper, 2023 · strength 0.15
- Edna Cukierman · 1 shared paper, 2023 · strength 0.15
- Christos K Fountzilas · 1 shared paper, 2023 · strength 0.15
- H. Carlo Maurer · 1 shared paper, 2020 · strength 0.12
- Kenneth P. Olive · 1 shared paper, 2020 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.